Prenyltransferase inhibitors for ocular hypertension control...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/166 (2006.01) A61K 31/417 (2006.01) A61K 31/4709 (2006.01) A61P 27/06 (2006.01) A61K 31/4178 (2006.01)

Patent

CA 2645171

The invention concerns in one embodiment a method of treating glaucoma or elevated intraocular pressure comprising administering a pharmaceutically effective amount of a composition comprising at least one prenyltransferase inhibitor. In another embodiment, the invention concerns a composition for the treatment of elevated intraocular pressure and glaucoma comprising a pharmaceutically effective amount of a prenyltransferase inhibitor.

L'invention concerne, dans un mode de réalisation, une méthode pour traiter un glaucome ou une pression intraoculaire élevée qui consiste à administrer une quantité pharmaceutiquement efficace d'une composition comprenant au moins un inhibiteur de la prenyl transférase. Dans un autre mode de réalisation, l'invention concerne une composition pour le traitement de la pression intraoculaire élevée et du glaucome qui comprend une quantité pharmaceutiquement efficace d'un inhibiteur de la prenyl transférase.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Prenyltransferase inhibitors for ocular hypertension control... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prenyltransferase inhibitors for ocular hypertension control..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prenyltransferase inhibitors for ocular hypertension control... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1978766

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.